Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,06119,080 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2021 – 2026

Summary Chemotherapy is a mainstream treatment for most cancers, despite recent progress in the development of new therapies for cancer. A well-documented long lasting toxicity of...

$4.08M
USD
Completed NON-SBIR/STTR RPGS
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Although genome-wide association studies (GWAS) have been extremely successful in identifying numerous germline variants associated to risk for prostate ca...

$6.41M
USD
Completed NON-SBIR/STTR RPGS
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2021 – 2026

Summary Chemotherapy is a mainstream treatment for most cancers, despite recent progress in the development of new therapies for cancer.A well-documented long lasting toxicity of s...

$4.2M
USD
Completed TRAINING, INDIVIDUAL
Exosomal CD44 in the metastasis of triple negative breast cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2023

Abstract The objective of this proposal is to determine the functions of breast cancer cell-secreted exosomes in regulating tumor motility, stemness, and immune evasion.Our prelimi...

$748.9K
USD
Completed NON-SBIR/STTR RPGS
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Although genome-wide association studies (GWAS) have been extremely successful in identifying numerous germline variants associated to risk for prostate ca...

$7.14M
USD
Completed TRAINING, INDIVIDUAL
Evaluating the role of EZH2-interacting protein (EZHIP) in pediatric posterior fossa ependymoma metabolism
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2023

ABSTRACT Pediatric ependymomas are the third-most common malignancy of the central nervous system.While they arise in different places of the neuraxis, these tumors are most common...

$379.9K
USD
Completed NON-SBIR/STTR RPGS
Social Health, Activity Behaviors, and Quality of Life among Young Adult Cancer Survivors: A Longitudinal Study
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

Abstract Approximately 70,000 adolescents and young adults are diagnosed with cancer between the ages of 15-39 in the U.S. every year.Due to their age and life stage, the experienc...

$6.6M
USD
Completed NON-SBIR/STTR RPGS
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Radiation plays a central role in the management of the most lethal central nervous system malignancy, glioblastoma (GBM), yet local control rates, and hen...

$4.86M
USD
Completed OTHER RESEARCH-RELATED
Mechanisms of translational output control in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2023

PROJECT SUMMARY My long-term career goal is to lead a productive academic research group, promoting science by conducting impactful cancer biology research and mentoring the next g...

$1.12M
USD
Completed NON-SBIR/STTR RPGS
Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2024

ABSTRACT Gynecologic cancers are among the leading causes of cancer death in women worldwide. These patients typically are socioeconomically disadvantaged, with poor access to scre...

$2.76M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2021 – 2026

PROJECT SUMMARY Chromatin-based DNA damage response (DDR) pathway is fundamental for protecting cells from genome instability, which is a hallmark of cancer. The DDR pathway is tig...

$2.03M
USD
Completed OTHER RESEARCH-RELATED
Integrative Prediction of Therapeutic Response in T-cell Lymphoma by Omic and Spatial Modeling
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2023

ABSTRACT The tumor ecosystem plays a critical role in tumor development, progression and therapeutic response.Previous studies have utilized dissociative and single-cell omics tech...

$1.36M
USD
Completed NON-SBIR/STTR RPGS
Image-based models of tumor-immune dynamics in glioblastoma
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2021 – 2026

ABSTRACT The use of immunotherapy to treat cancer continues to generate hope and excitement among those involved in cancer care and research.However, our inability to explain why s...

$7.86M
USD
Completed NON-SBIR/STTR RPGS
Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

The goal of this proposal is to define the role of each component of the ARTN/GFR?3/TRPM8 signaling pathway in radiation-associated pain (RAP). A common consequence of radiotherapy...

$3.61M
USD
Completed NON-SBIR/STTR RPGS
Targeting Nucleotide Metabolism to Overcome Therapy Resistance in Glioblastoma
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2026

ABSTRACT Glioblastoma (GBM) is the most common aggressive primary brain tumor and is uniformly fatal with a median survival of around 1.5-years.Like surgery and chemotherapy, radia...

$5.55M
USD
Completed NON-SBIR/STTR RPGS
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2025

The five year survival rate for lung cancer is ~20% despite improved screening methods and advances in treatment. Tumor metastasis is one of the major causes of death in cancer pat...

$4.42M
USD
Completed NON-SBIR/STTR RPGS
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

Abstract: Immunotherapy is becoming a pillar of cancer treatment, and many responsive patients have experienced durable, or even curative, outcomes.For reasons that remain unclear,...

$3.52M
USD
Completed NON-SBIR/STTR RPGS
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2026

Project Summary The overarching goal of this project is to develop a tumor organoid-based drug screening platform that quantifies the differential drug responsiveness of tumor clon...

$5.01M
USD
Completed NON-SBIR/STTR RPGS
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory Oncology
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

Abstract Depressionis one of the most common psychological comorbidities experienced throughout the cancercontinuum.Elevated depressive symptoms in oncology patients is a major con...

$6.85M
USD
Completed OTHER RESEARCH-RELATED
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2023

PROJECT SUMMARY: Glioblastoma (GBM) is the most common primary malignant brain tumor, with a median survival of up to 20 months. Males have a 1.6-fold higher incidence of GBM compa...

$1.2M
USD